Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Revision as of 17:56, 16 June 2009 by Swilliams (talk | contribs)
Jump to navigation Jump to search
Conduction
Sinus rhythm
Atrial fibrillation
Atrihttp://miles.wikidoc.org/skins/common/images/button_bold.pngal fibrillation
The P waves, which represent depolarization of the atria, are irregular or absent during atrial fibrillation.
ICD-10 I48
ICD-9 427.31
DiseasesDB 1065
MedlinePlus 000184
eMedicine med/184  emerg/46

WikiDoc Resources for Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Articles

Most recent articles on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Most cited articles on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Review articles on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Articles on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Images of Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Photos of Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Podcasts & MP3s on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Videos on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Evidence Based Medicine

Cochrane Collaboration on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Bandolier on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

TRIP on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Clinical Trials

Ongoing Trials on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes at Clinical Trials.gov

Trial results on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Clinical Trials on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

NICE Guidance on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

NHS PRODIGY Guidance

FDA on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

CDC on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Books

Books on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

News

Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes in the news

Be alerted to news on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

News trends on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Commentary

Blogs on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Definitions

Definitions of Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Patient Resources / Community

Patient resources on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Discussion groups on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Patient Handouts on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Directions to Hospitals Treating Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Risk calculators and risk factors for Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Healthcare Provider Resources

Symptoms of Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Causes & Risk Factors for Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Diagnostic studies for Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Treatment of Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Continuing Medical Education (CME)

CME Programs on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

International

Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes en Espanol

Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes en Francais

Business

Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes in the Marketplace

Patents on Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Experimental / Informatics

List of terms related to Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes

Cardiology Network

Discuss Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Synonyms and related keywords: AF, Afib, fib

Overview

ACC / AHA Guidelines- Wolff-Parkinson-White Preexcitation Syndromes (DO NOT EDIT) [1]

Class I

1. Catheter ablation of the accessory pathway is recommended in symptomatic patients with AF who have WPW syndrome, particularly those with syncope due to rapid heart rate or those with a short bypass tract refractory period. (Level of Evidence: B)

2. Immediate direct-current cardioversion is recommended to prevent ventricular fibrillation in patients with a short anterograde bypass tract refractory period in whom AF occurs with a rapid ventricular response associated with hemodynamic instability. (Level of Evidence: B)

3. Intravenous procainamide or ibutilide is recommended to restore sinus rhythm in patients with WPW syndrome in whom AF occurs without hemodynamic instability in association with a wide QRS complex on the ECG (greater than or equal to 120-ms duration) or with a rapid pre-excited ventricular response. (Level of Evidence: C)

Class IIa

1. Intravenous flecainide or direct-current cardioversion is reasonable when very rapid ventricular rates occur in patients with AF involving conduction over an accessory pathway. (Level of Evidence: B)

Class IIb

Class III

Sources

  • The ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation [1]

References

  1. 1.0 1.1 Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation- Executive Summary: executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidlines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006; 114: 700-752. PMID 16908781

Further Readings

  • Fuster V, Rydén LE, Cannom DS, et al (2006). "ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation 114 (7): e257-354. doi:10.1161/CIRCULATIONAHA.106.177292. PMID 16908781.
  • Estes NAM 3rd, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS, McNamara RL, Messer JV, Ritchie JL, Romeo SJW, Waldo AL, Wyse DG. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with non valvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Performance Measures for Atrial Fibrillation). Circulation 2008; 117:1101–1120

Template:SIB

de:Vorhofflimmern it:Fibrillazione atriale nl:Boezemfibrilleren no:Atrieflimmer fi:Eteisvärinä


Template:WikiDoc Sources